Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary Care: A SNOCAP report

Annals of Family Medicine

Volumn 7, Issue 1, 2009, Pages 41-46

  Parnes, Bennett ^a,b,d   Smith, Peter C ^a,d   Gilroy, Christine ^a   Quintela, Javan ^a   Emsermann, Caroline B ^a   Dickinson, L Miriam ^a   Westfall, John M ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Research Network ^*  (United States)

^c High Plains Research Network (HPRN)   (United States)

^d Building InvestiGative Practices for Better Health Outcomes Research Network ^*  (United States)

Author keywords

Direct to consumer advertising (DTCA); Pphysician patient relationship; Practice based research networks

Indexed keywords

EID: 61449146970     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.870     Document Type: Article

References (19)

1. Brownfield ED, Bernhardt JM, Phan JL, Williams MV, Parker RM. Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement. J Health Commun. 2004;9(6):491-497.
2. Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG. Demand Effects of Recent Changes in Prescription Drug Promotion. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2003.
3. Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising. Washington, DC: United States Government Accountability Office; 2006. Report GAO-07-54.
4. Freudenheim M. Showdown looms in congress over drug advertising on TV. NY Times. January 22, 2007.
5. Aikin KJ, Swasy JL, Braman AC. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results. Washington, DC: US Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research; 2004.
6. Peyrot M, Alperstein NM, Van Doren D, Poli LG. Direct-to-consumer ads can influence behavior. Mark Health Serv. 1998;18(2):26-32.
7. Petroshius SM, Titus PA, Hatch KJ. Physician attitudes toward pharmaceutical drug advertising. J Advert Res. 1995;35(6):41-51.
8. Hollon MF. Direct-to-consumer marketing of prescription drugs. JAMA. 1999;281(4):382-384.
9. Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood). 2006;25(5):1371-1377.
10. Kessler DA, Levy DA. Direct-to-consumer advertising: is it too late to manage the risks? Ann Fam Med. 2007;5(1):4-5.
11. Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med. 2007;5(1):6-13.
12. Spence MM, Teleki SS, Cheetham TC, Schweitzer SO, Millares M. Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev. 2005;62(5):544-559.
13. Stange KC. Time to ban direct-to-consumer prescription drug marketing. Ann Fam Med. 2007;5(2):101-104.
14. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A. et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. [see comment]. CMAJ. 2003;169:405-412.
15. Berenson A. Big drug makers see sales decline with their image. NY Times. November 14, 2005.
16. Alina B, Stratton K, Burke SP, eds. Institute of Medicine. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: The National Academies Press; 2007.
17. Parnes BL, Main DS, Dickinson LM, et al. Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN. Diabetes Care. 2004;27(1):13-16.
18. Parnes B, Niebauer L, Holcomb S, et al. Provider deferred decisions on hemoglobin A1c results: a report from the Colorado Research Network (CaReNet) and the High Plains Research Network (HPRN). J Am Board Fam Med. 2006;19(1):20-23.
19. Smith PC, Araya-Guerra R, Bublitz C, et al. Missing clinical information during primary care visits. JAMA. 2005;293(5):565-571.